Statements (19)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:activeIngredient |
C1 esterase inhibitor (human)
|
gptkbp:approvalYear |
2017
|
gptkbp:approvedBy |
gptkb:FDA
|
gptkbp:ATCCode |
B06AC02
|
gptkbp:form |
lyophilized powder for solution for injection
|
https://www.w3.org/2000/01/rdf-schema#label |
Haegarda
|
gptkbp:indication |
prevention of hereditary angioedema attacks
|
gptkbp:manufacturer |
gptkb:CSL_Behring
|
gptkbp:prescriptionStatus |
prescription only
|
gptkbp:routeOfAdministration |
subcutaneous injection
|
gptkbp:sideEffect |
dizziness
headache injection site reaction hypersensitivity |
gptkbp:storage |
refrigerated
|
gptkbp:usedFor |
gptkb:hereditary_hemorrhagic_telangiectasia
|
gptkbp:bfsParent |
gptkb:C1_esterase_inhibitor
|
gptkbp:bfsLayer |
8
|